Metabolic syndrome in schizophrenia: Differences between antipsychotic-naïve and treated patients.
about
From Molecules to the Clinic: Linking Schizophrenia and Metabolic Syndrome through Sphingolipids MetabolismMetabolic syndrome among psychiatric outpatients with mood and anxiety disorders.The comparison of glucose and lipid metabolism parameters in drug-naïve, antipsychotic-treated, and antipsychotic discontinuation patients with schizophrenia.An eight-year clinic experience with clozapine use in a Parkinson's disease clinic setting.Weight Gain and Its Correlates Among Forensic InpatientsBeyond the brain: disrupted in schizophrenia 1 regulates pancreatic β-cell function via glycogen synthase kinase-3β.The metabolic syndrome and schizophrenia: A comorbidity or an association?The Obesity-Impulsivity Axis: Potential Metabolic Interventions in Chronic Psychiatric Patients.Metabolic Syndrome Screening and Assertive Community Treatment: A Quality Improvement Study.Persistence of racial disparities in prescription of first-generation antipsychotics in the USA.Metabolic syndrome in antipsychotic naive African patients with severe mental illness in usual care.Association Between 5-HTR2C -759C/T (rs3813929) and -697G/C (rs518147) Gene Polymorphisms and Risperidone-Induced Insulin Resistance Syndrome in an Indian Population.The Wnt Signaling Pathway Effector TCF7L2 Mediates Olanzapine-Induced Weight Gain and Insulin Resistance.
P2860
Q28067617-6EBC1847-B1FA-4298-A224-CE70F7744B37Q33836586-544315CB-EBF6-4CE0-BA1A-B97B2B268251Q33968686-10416FD3-D426-4A44-B645-532DD2EC35BFQ35124915-FA1962A9-84DC-45C4-9B60-0E9E02BA4E95Q35794607-B4BDE21F-B5F1-416A-AABC-0825B4A8DE90Q36466996-F0BD6146-446C-4CE5-BFB8-86385E6D203BQ37102217-7788A4E0-99E0-4289-8E93-4AD67ABD4DACQ37637480-7DBA585E-751E-4F16-BD68-E659AF27040FQ40306195-516850F5-1ADB-434C-BB53-3FFDB3890A9BQ40778551-866FBC29-3C2C-4C83-B957-3DD3CE573262Q46620550-97B26DC4-B5AD-4743-9D79-A4BC546205E3Q48304926-4104DCF3-B4DB-4867-8BC4-386E28A4CD29Q53689686-6640DC44-B0AF-4E12-867C-E6D5616E886B
P2860
Metabolic syndrome in schizophrenia: Differences between antipsychotic-naïve and treated patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metabolic syndrome in schizoph ...... ic-naïve and treated patients.
@en
Metabolic syndrome in schizoph ...... ic-naïve and treated patients.
@nl
type
label
Metabolic syndrome in schizoph ...... ic-naïve and treated patients.
@en
Metabolic syndrome in schizoph ...... ic-naïve and treated patients.
@nl
prefLabel
Metabolic syndrome in schizoph ...... ic-naïve and treated patients.
@en
Metabolic syndrome in schizoph ...... ic-naïve and treated patients.
@nl
P2093
P2860
P356
P1476
Metabolic syndrome in schizoph ...... ic-naïve and treated patients.
@en
P2093
Koushik S Deb
Mamta Sood
Prashanth Ramshankar
Rakesh K Chadda
P2860
P304
P356
10.4103/0976-500X.114596
P577
2013-07-01T00:00:00Z